330 related articles for article (PubMed ID: 8157194)
21. Clinical value of intraoperative gross examination in endometrial cancer.
Franchi M; Ghezzi F; Melpignano M; Cherchi PL; Scarabelli C; Apolloni C; Zanaboni F
Gynecol Oncol; 2000 Mar; 76(3):357-61. PubMed ID: 10684710
[TBL] [Abstract][Full Text] [Related]
22. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic consistency between endometrial hyperplasia diagnosis from endometrial curettage and pathologic diagnoses from hysterectomy specimens.
Jesadapatrakul S; Tangjitgamol S; Manusirivitaya S
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S16-21. PubMed ID: 17722313
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.
Fotiou S; Vlahos N; Kondi-Pafiti A; Zarganis P; Papakonstantinou K; Creatsas G
Gynecol Oncol; 2009 Mar; 112(3):517-20. PubMed ID: 19117598
[TBL] [Abstract][Full Text] [Related]
25. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
26. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
28. Comparison of examination of the entire uterine cervix with routine cervical sampling in hysterectomy specimens from women with endometrial cancer.
Nayar AG; Cross PA; Bulmer JN; Deen S; El-Sherif A
J Clin Pathol; 2008 May; 61(5):621-2. PubMed ID: 18006669
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
30. [Atypical endometrial hyperplasia. Prognosis and course].
Jensen HH; Hussain SF; Pedersen PH; Andreasson B
Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
[TBL] [Abstract][Full Text] [Related]
31. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
32. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
Seago DP; Raman A; Lele S
Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
[TBL] [Abstract][Full Text] [Related]
33. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
34. Clinical factors affecting the diagnostic accuracy of assessing dilation and curettage vs frozen section specimens for histologic grade and depth of myometrial invasion in endometrial carcinoma.
Wang X; Zhang H; Di W; Li W
Am J Obstet Gynecol; 2009 Aug; 201(2):194.e1-194.e10. PubMed ID: 19564019
[TBL] [Abstract][Full Text] [Related]
35. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
36. The value of curettage in diagnosis of endometrial hyperplasia.
Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
[TBL] [Abstract][Full Text] [Related]
37. [Incidence of endometrial carcinoma after hysterectomy for atypical hyperplasia or FIGO stage IA carcinoma diagnosed on endometrial biopsy or endometrial resection].
Ploteau S; Squifflet JL; Berlière M; Marbaix E; Donnez J
Bull Cancer; 2008 May; 95(5):556-62. PubMed ID: 18541521
[TBL] [Abstract][Full Text] [Related]
38. The risk of premalignant and malignant pathology in endometrial polyps.
Bakour SH; Khan KS; Gupta JK
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
40. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
